ArticleFrontiers in oncology2022

The CURB65 score predicted 180-day mortality of non-small cell lung carcinoma patients with immune checkpoint inhibitor-associated pneumonitis: A pilot retrospective analysis.

Fen Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.